...
首页> 外文期刊>Clinical and diagnostic laboratory immunology >A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies.
【24h】

A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies.

机译:一种快速灵敏的化学发光测定法,用于评估流感嗜血杆菌b型特异性抗体的功能性调理活性。

获取原文
           

摘要

Luminol-enhanced chemiluminescence (CL) of heterologous neutrophils was used to assess the capacity of a 1-ng/ml concentration of Haemophilus influenzae type b (Hib)-specific antibodies to induce opsonization of Hib with autologous heat-inactivated sera from children immunized with Hib capsular polysaccharide-polyribosylribitolphosphate (Hib-PRP) conjugate vaccine. Serum samples from 15 of 36 children (42%) vaccinated with Hib-PRP conjugate vaccine had protective levels of Hib-specific antibodies of > or = 1,000 ng/ml. Ten of these 15 (67%) had poor or nonfunctional opsonic activity. Of the 10 children whose sera lacked opsonic activity, 5 (50%) presented with recurrent Hib infection. In contrast, none of the sera of 20 healthy adults lacked opsonic capability. CL intensity was proportional to the concentration of anti-Hib antibodies used for opsonization. Furthermore, the titers of Hib-PRP-specific antibody in children and adults did not correlate with opsonic activity. These results suggest that luminol-enhanced CL as described here with minute concentrations of antibody for opsonization can be used to assess functional capacity of anti-Hib antibodies after vaccination or natural infection in the evaluation of patients with recurrent infections.
机译:异源嗜中性粒细胞的鲁米诺增强化学发光(CL)用于评估浓度为1 ng / ml的B型流感嗜血杆菌(Hib)特异性抗体诱导自体免疫灭活的血清免疫接种儿童的Hib的调理作用的能力。 Hib荚膜多糖-聚核糖基核糖醇磷酸(Hib-PRP)结合疫苗。接种了Hib-PRP结合疫苗的36名儿童中有15名(42%)的血清样本的Hib特异性抗体的保护水平大于或等于1,000 ng / ml。这15个中有10个(67%)的调理活动差或无功能。在血清中没有调理活性的10名儿童中,有5名(50%)出现了复发性Hib感染。相反,20名健康成年人的血清中没有一个没有调理能力。 CL强度与用于调理作用的抗-Hib抗体的浓度成正比。此外,儿童和成人中Hib-PRP特异性抗体的滴度与调理活性无关。这些结果表明,如本文所述的鲁米诺增强的CL和微量浓度的调理抗体,可用于评估疫苗或自然感染后抗Hib抗体在评估复发感染患者中的功能能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号